BIOCONVERGENT Trademark

Trademark Overview


On Thursday, December 16, 2021, a trademark application was filed for BIOCONVERGENT with the United States Patent and Trademark Office. The USPTO has given the BIOCONVERGENT trademark a serial number of 97174698. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, January 31, 2024. This trademark is owned by BioConvergent Health, LLC. The BIOCONVERGENT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the fields of pharmaceuticals, medical devices, cell therapy, diagnostics, health care data reporting and informatics; consulting services in the fields of pharmaceuticals, medical devices, cell therapy, diagnostics, health care data reporting, and informatics; consulting services for others in the field of design, planning, and implementation project management of clinical trials; advisory services in the fields of fields of pharmaceuticals, medical devices, cell therapy, diagnostics, health care data reporting, and informatics
bioconvergent

General Information


Serial Number97174698
Word MarkBIOCONVERGENT
Filing DateThursday, December 16, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, January 31, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkBIO CONVERGENT
Goods and ServicesResearch and development in the fields of pharmaceuticals, medical devices, cell therapy, diagnostics, health care data reporting and informatics; consulting services in the fields of pharmaceuticals, medical devices, cell therapy, diagnostics, health care data reporting, and informatics; consulting services for others in the field of design, planning, and implementation project management of clinical trials; advisory services in the fields of fields of pharmaceuticals, medical devices, cell therapy, diagnostics, health care data reporting, and informatics

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 20, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBioConvergent Health, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressPurchase, NY 10577

Trademark Events


Event DateEvent Description
Wednesday, January 31, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, January 31, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, January 31, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, October 3, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, October 3, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, July 7, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, July 7, 2023FINAL REFUSAL E-MAILED
Friday, July 7, 2023FINAL REFUSAL WRITTEN
Thursday, March 30, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 28, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 28, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 29, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 29, 2022NON-FINAL ACTION E-MAILED
Thursday, September 29, 2022NON-FINAL ACTION WRITTEN
Thursday, September 22, 2022ASSIGNED TO EXAMINER
Monday, December 20, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 20, 2021NEW APPLICATION ENTERED